ケーススタディ：MorphoSys社、Genedata Biologicsで抗体の研究開発を加速

The MorphoSys implementation of Genedata Biologics® as their end-to-end workflow platform has resulted in a significant increase of efficiency across all R&D functions, including library generation, screening and selection, molecular biology, antibody screening, protein engineering, expression, purification, and analytics.